Ipharm 4sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-04-26
Share capital
125,000.00 PLN
Registered address
Białobrzeska 45, 41-409 Mysłowice, Poland
Electronic delivery address
AE:PL-21547-23571-TSGAB-28

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2025, 9 days late).

  • 202524/07/2026
  • 202410/07/2025
  • 202321/06/2024
  • 202221/06/2023
  • 202106/07/2022
  • 202008/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.57mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 75.34kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 1.48mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 291.72kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Ipharm 4 has been an NFZ healthcare provider since 2023. In 2026 it is performing 1 contract worth USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesśląskie1USD 0.00

Authorized Representatives

Adam Marcin Pecyna – Attorney-in-fact (sole)
Anna Palka Porwit – Attorney-in-fact (sole)
Aleksander Porwit – President of the Management Board

Manner of representation

The company is represented by each member of the management board independently.

Ownership

OwnerSharesShare valueStake
1,275$17,220.4251%
Aleksander Porwitage 50
1,225$16,545.1149%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2014-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $44,139.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,805
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,352
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$36,572

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2023-03-16PKD change
2014-05-08Share capital increase
2013-04-26Entered in the register

FAQ

Last updated: 2026-07-24